The management of Proliferative Diabetic Retinopathy primarily focuses on reducing the production of VEGF by ischemic tissue through laser photocoagulation or intravitreal anti-VEGF injections. The gene discussed is VEGFA; the disease is proliferative diabetic retinopathy.